Clinical trial reportEuropean journal of cancer (Oxford, England : 1990)Published
Assessing time to symptomatic progression, a patient-relevant efficacy endpoint, in the MARIPOSA study in non-small cell lung cancer
15 of 31 authors shown in byline order.
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- County
- Montgomery County
Publication record
- Type
- Clinical trial report
- Venue
- European journal of cancer (Oxford, England : 1990)
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Disease Progression; Acrylamides; Aniline Compounds; Pyrimidines; Indoles; Quinolines; Antineoplastic Combined Chemotherapy Protocols; Treatment Outcome; Time Factors
- PubMed ID
- 42492306
- Added to directory
- Source checked